BAFNA PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Bafna Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.97₹ 8.3
As on Sep 26, 2025, 3:27 PM IST
Bafna Pharmaceuticals Price Performance
Today's LowToday's High
₹158.55₹175.15
₹175.15
52 Weeks' Low52 Weeks' High
₹67.80₹166.85
₹175.15
Open Price
₹175.15
Prev. Close
₹166.85
Volume
14,916
Over the last 5 years, the share price of Bafna Pharmaceuticals has gained 66.47% CAGR. Over the past year, the corresponding return has been 103.80%.
Bafna Pharmaceuticals’s current P/E of -16.76x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Bafna Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bafna Pharmaceuticals | 27.52 | 76.92 | 135.39 | 127.47 | 103.80 | 20.58 | 66.47 |
| Sun Pharmaceutical Industries | -4.69 | -1.37 | -5.44 | -10.20 | -16.85 | 20.71 | 25.34 |
| Divi's Laboratories | -8.01 | -7.89 | -13.78 | -2.35 | 6.01 | 15.83 | 13.01 |
| Cipla | -4.96 | -5.22 | -1.02 | 1.48 | -7.69 | 12.01 | 14.09 |
| Torrent Pharmaceuticals | -2.24 | -1.46 | 10.05 | 10.27 | 4.11 | 32.85 | 21.40 |
| Dr. Reddy's Laboratories | -5.07 | -0.61 | -4.96 | 7.89 | -6.90 | 14.96 | 4.13 |
| Mankind Pharma | -6.63 | -0.64 | 7.90 | 3.20 | -7.44 | 20.39 | 11.78 |
| Zydus Lifesciences | -5.14 | -0.39 | 0.16 | 8.45 | -7.93 | 40.33 | 20.29 |
| Lupin | -6.73 | -0.31 | -0.43 | -6.81 | -12.32 | 43.11 | 13.73 |
| Alkem Laboratories | -1.83 | 0.29 | 12.18 | 8.70 | -12.35 | 18.19 | 14.41 |
| Abbott India | -0.67 | -5.74 | -9.20 | -1.59 | 3.11 | 19.62 | 13.02 |
| Aurobindo Pharma | -2.74 | 4.06 | -3.16 | -6.00 | -28.23 | 29.40 | 6.29 |
| Glenmark Pharmaceuticals | -5.70 | 0.68 | 13.53 | 34.26 | 17.22 | 74.81 | 31.74 |
| Biocon | -7.45 | -4.70 | -2.51 | -1.88 | -8.26 | 7.38 | -5.37 |
| GlaxoSmithKline Pharmaceuticals | -2.36 | -4.12 | -18.93 | -5.22 | -1.95 | 24.32 | 11.13 |
| Laurus Labs | -10.47 | -3.94 | 22.57 | 35.70 | 79.99 | 18.99 | 23.36 |
| Anthem Biosciences | -7.09 | -5.80 | 7.72 | 7.72 | 7.72 | 2.51 | 1.50 |
| Ipca Laboratories | -4.42 | -4.45 | 1.64 | -5.30 | -7.59 | 15.20 | 5.64 |
| Cohance Lifesciences | -4.15 | -1.04 | -13.01 | -21.70 | -25.93 | 27.69 | 16.83 |
| Gland Pharma | -3.10 | 1.60 | 9.29 | 21.01 | 6.08 | -1.72 | 1.48 |
Over the last one year, Bafna Pharmaceuticals has gained 103.80% compared to peers like Sun Pharmaceutical Industries (-16.85%), Divi's Laboratories (6.01%), Cipla (-7.69%). From a 5 year perspective, Bafna Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.34%) and Divi's Laboratories (13.01%).
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 137.69 | 152.85 |
| 10 | 126.89 | 140.86 |
| 20 | 114.38 | 127.21 |
| 50 | 101.16 | 109.56 |
| 100 | 89.41 | 98.06 |
| 200 | 84.36 | 90.92 |
Bafna Pharmaceuticals Share Holding Pattern
In the latest quarter, Bafna Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 9.34%, and public shareholding moved down to 15.66% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bafna Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 20, 2025, 12:08 AM IST | Bafna Pharmaceutical - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 20, 2025, 12:03 AM IST | Bafna Pharmaceutical - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Sep 19, 2025, 9:27 PM IST | Bafna Pharmaceutical - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 26, 2025, 11:33 PM IST | Bafna Pharmaceutical - Notice Of 30Th Annual General Meeting Of The Company For The F.Y 2024-2025 |
| Aug 26, 2025, 11:27 PM IST | Bafna Pharmaceutical - Reg. 34 (1) Annual Report. |
About Bafna Pharmaceuticals
Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 145.86 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBafna Towers, Chennai (Madras) Tamil Nadu 600001
- Contact
Management
- Mrs. S HemalathaWhole Time Director
- Mr. Vinayak Dinesh DendukuriWhole Time Director
- Mr. Upendar Mekala ReddyNon Exe.Non Ind.Director
- Mrs. Akila C RajuNon Exe.Non Ind.Director
- Ms. R ChitraInd. Non-Executive Director
- Mr. Navin KumarInd. Non-Executive Director
FAQs on Bafna Pharmaceuticals Share Price
What is the share price of Bafna Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bafna Pharmaceuticals is ₹175.15 as on Sep 26, 2025.
What kind of stock is Bafna Pharmaceuticals?
The Bafna Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bafna Pharmaceuticals?
The market cap of Bafna Pharmaceuticals is ₹414.34 Cr as on Sep 26, 2025.
What are today's High and Low prices of Bafna Pharmaceuticals?
Today’s highest and lowest price of Bafna Pharmaceuticals are ₹175.15 and ₹158.55.
What are the 52 Week High and 52 Week Low of Bafna Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Bafna Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Bafna Pharmaceuticals is ₹166.85 and 52-week low of Bafna Pharmaceuticals is ₹67.80 as on Sep 26, 2025.
How has the Bafna Pharmaceuticals performed historically in terms of returns?
The Bafna Pharmaceuticals has shown returns of 4.97% over the past day, 76.92% for the past month, 135.39% over 3 months, 103.8% over 1 year, 20.58% across 3 years, and 66.47% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bafna Pharmaceuticals?
P/E ratio of and PB ratio of Bafna Pharmaceuticals are -16.76 and 24.30 on Sep 26, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data